After four years of stagnation, the pharmaceutical sector experienced a turnaround this year, leading the pack among various industry segments. However, recent signs indicate a shift in fund allocation patterns, with funds no longer clustering as tightly in this sector. Some industry insiders anticipate that the market may follow a "medicines first, medical treatments later" trajectory this year, forecasting that the medical device sector, which has lagged behind in gains, is poised for catch-up growth.